COVID-19 Request Received

Thank you for getting in touch with us regarding your interest in COVID-19 biosamples. Our team will be in touch as soon as possible.

We remain committed to doing everything we can to support ongoing research in this area, and we appreciate your feedback and participation as we work to deliver the critical research materials you need. Thank you for allowing us to be part of the work you do!

Your source for all 
things biotech

Stay informed with our expert insights, industry news, and groundbreaking discoveries.

News

FAQs regarding Human Serum

DOES YOUR SERUM CONTAIN TETRACYCLINE?We do not add this antibiotic to serum during manufacturing. Tetracycline is an antibiotic which is...

Stem cell research needs breakthroughs
Stem cell research needs breakthroughs
News

Stem cell research needs breakthroughs

Stem cell-based therapeutics are a fast-growing area of early-stage biotech research, targeting diseases fromamyotrophic lateral sclerosisandDuchenne muscular dystrophytocancerandHIV, supportingregenerative medicine,...

News

Targeting VEGF could do more harm than good in the eye

Preclinical studies have raised a potential red flag on anti-VEGF therapies, suggesting that increasingly aggressive use in eye disease could trip...

News

New References Published

Innovative Research has had several new references in publications over the past week. Below are just a few of the...

News

Fate's tissue regeneration proteins validated in vivo

San Diego-based Fate Therapeutics, which focuses on the discovery and development of adult stem cell modulators, has announced that its...